V
VNDA
Vanda Pharma
6.19
-0.02-0.32%After Hours: 6.15 -0.04 -0.65%19:58 05/22 EDT
OPEN/PREV CLOSE6.19/6.21
TODAY RANGE6.13-6.23
VOL884.20K
MARKET CAP372.24M
52 WEEK RANGE4.140-9.94
AVG VOL (3M)1.65M
% TURNOVER1.47%
TURNOVER--
P/E (TTM)-1.5287
% RANGE1.61%
EPS(TTM)-4.0491
P/E(FORWARD)-2.5579
P/B1.326
BVPS4.669
DIVIDEND--
P/S1.693
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP336.91M
SHARES OUTSTANDING60.14M
NEXT EARNINGS07/29-08/03
FREE FLOAT54.43M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·05/15 20:33
Corbus Pharmaceuticals Holdings Inc. Stock Slides 7.9%, Underperforms Peers
Dow Jones·05/13 20:33
Corbus Pharmaceuticals Holdings Inc. Stock Advances 6.3%, Outperforms Peers
Seeking Alpha·05/13 17:34
Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss
Dow Jones·05/11 11:14
Vanda Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
TipRanks·05/11 10:50
Vanda Pharmaceuticals price target lowered to $21 from $24 at H.C. Wainwright
TipRanks·05/08 02:23
Vanda Pharmaceuticals Bets Big on Growth Pipeline
TipRanks·05/07 11:36
Truist Financial Sticks to Its Buy Rating for Vanda (VNDA)
Seeking Alpha·05/07 09:02
Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook